Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes...

43
Quantitative description of the effects of a drug on the body titative , time-dependent changes lasma and total drug concentration Pharmacokinetics and Pharmacodynamics

Transcript of Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes...

Page 1: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Quantitative description of the effects of a drug on the body

Quantitative , time-dependent changesof plasma and total drug concentration

Pharmacokinetics and Pharmacodynamics

Page 2: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

2

Pharmacokinetics and Pharmacodynamics

• Pharmacodynamics is the study of how drugs interact with a molecular target, i.e; effect of the drug on the body.

• Pharmacokinetics is the study of how a drug reaches its target in the body and how it is affected on that journey, i.e; effect of the body on the drug.

• Pharmacokinetics is the study of how is the drug absorbed, distributed, metabolized and excreted in the body

Page 3: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.
Page 4: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Response proportional Number of receptors

Page 5: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Efficacy is the maximal response a drug can produce

Potency is a measure of the dose needed to produce a response and is expressed as the dose required to achieve 50% of the desired therapeutic effect.

Page 6: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.
Page 7: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

TI= TD50

ED50

Page 8: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.
Page 9: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

e.g. Heparin TI < 2 measure PTTAspirin TI 1000

Page 10: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

4.Therapeutic Effect and Adverse Action

Page 11: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Clinical effects of drug action have the dualism, The aim of drug therapy is to cure or suppress disease, called therapeutic action, but also bring about some harmful effects, named untoward or adverse reaction.

Therapeutic Effect It implied the effects that conform the goal of therapy, including

etiological treatment and symptomatic treatment.• 1. etiological treatment implies primary therapy (e.g. in bacterial and

parasitic infections), when the disease is eliminated and the drug is withdrawn; or auxiliary therapy, also called supplement therapy or replacement therapy.

• 2. symptomatic treatment means suppression of diseases or symptoms is used continuously or intermittently to maintain health without attaining cure (as in hypertension, diabetes, epilepsy, asthma) or to control symptoms (such as pain and cough) whilst awaiting recovery from the causative disease.

Generally, etiological treatment is more important than symptomatic treatment. However, symptomatic treatment is not necessarily trivial in emergency rescue, such as heart failure, shock, epilepsy, asthma, etc.

Page 12: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Adverse Reaction (Untoward)

The term adverse reaction is defined as unwanted, seriously unpleasant, or even harmful effects.

1. Side effects is to be the undesired effects unrelated to therapeutic aim and occurring at doses intended for therapeutic effect.

• ①It is often slight, recoverable functional alteration of the body.

• ②Some of side effects may make a quick recovery without withdrawal of the drug, but others dose not disappear until withdrawal of the drug.

• ③The pharmacological basis of side effect is lower selectivity

• ④Side effects vary with different therapeutic goals. For example, atropine is used as an antisecretory agent to block secretions in the upper and lower respiratory tracts prior to surgery .

• ⑤Usually drug in combination is the best way to prevent from side effects.

Page 13: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

2. Toxic reaction is the adverse reactions that occur frequently due to overdose or longterm use.

①Any drug in overdose could induce toxicity, which implied a direct action.The toxic reactions vary with different drugs, but much of the serious drug toxicity in clinical practice represents a direct pharmacological extension of the therapeutic action of the drug, thus they are predictable.

②The severity of a toxicity is deteriorated with dose increase, so we cannot rise the therapeutic effect by increasing doses of drug, which is very dangerous.

③Toxicity can not automatically disappear because it often damages the function or the morphology of organs, even inducing teratogenicity, carcinogenicity and mutagenicity.

Toxicities include the acute toxicity, subacute toxicity and chronic toxicity3. Residual effect implies the biological responses induced by residual drug

below effective concentration after cessation of administration, including a short period, long term and permanent.

4. Withdrawal reaction implies a worsening of original diseases occurred after suddenly cessation of administration, also called the rebound reaction.

Page 14: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Agonists and antagonists

Two states: closed or open

Page 15: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

An antagonist is a molecule that inhibits the action of an agonist buthas no effect in the absence of an agonist

e.g. protamine binds heparin

Page 16: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

e.g. aspirin is a noncompetitiveantagonist. It acetylates cyclooxygenase

-reduced efficacy-same potency

e.g. Pravastatin inhibits HMG CoAReductase, which is the rate limiting enzyme in cholesterol synthesis

Page 17: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.
Page 18: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Raloxifene = SERM (selective estrogen receptor antagonist

Bone is a Partial agonistBreast is an antagonist

Inverse agonist decrease inherent activity of receptor

e.g BCR-Abl

Spare receptors : a maximal response is achieved with < 100%occupancy e.g. GPCRs where one G protein can stimulate second messenger formation.

Page 19: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.
Page 20: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Thiopental and diazepam in fat

Heparin to plasma proteins

Page 21: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

First-PassMetabolism can occur with orally administered drugs

Page 22: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Bioavailability = Quantity of drug reaching the circulation Quantity of drug administered

1. First-Pass hepatic metabolism e.g P450 enzymes in liver transform drug2. Solubility: extremely hydrophilic and hydrophobic drugs are poorly absorbed3. Instability: penicillin G is unstable at low pH, insulin is digested

Page 23: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Routes of Drug AdministrationRoute Advantages DisadvantagesEnteral Simple, inexpensive Drug exposed to GI ande.g. aspirin painless first-pass metabolism,

slow delivery

Parenteral Rapid delivery Irreversible, infectione.g. morphine no first-pass metabolism pain, skilled personnel

high bioavailability

Mucous Rapid delivery, simple Few drugsBeclomethasone No first-pass metabolism(Sublingual,nasal, rectal) Direct delivery (lungs)

Transdermal Simple, prolonged admin. lipophilic drugNicotine No First-pass slow delivery

Page 24: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Parenteral Drug Administration

Advantages Disadvantages

Subcutaneous slow onset, oil based slow onset, small vol.Xylocaine

Intramuscular Intermediate onset, oil-based hemorrhage, painHaloperidol

Intravenous Rapid onset, controlled peak-related toxicitymorphine delivery

Intrathecal Bypasses BBB Infection, skilledmethotrexate personnel

Page 25: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.
Page 26: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.
Page 27: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.
Page 28: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

pKa= pH + log [HA] [A-]

3=log [HA] [A-]

1,000= [HA] [A-]

Page 29: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.
Page 30: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Most drugs are rapidly distributed from the systemic circulation to other compartments e.g. interstitium and adipose tissue See Table 3-3 e.g. diazepam (valium)

Half-life: time for drug conc to decrease to half its original value

First-order kinetics: the amount of drug metabolized or excreted is proportional to the conc in the systemic circulation i.e the fraction eliminated remains the same.

Page 31: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

e.g. WarfarinAnd fluoxetine (Prozac)

Page 32: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

METABOLISM

Page 33: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.
Page 34: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.
Page 35: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.
Page 36: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

45% whites and Blacks are slow acetylators; 90% Asians "Fast acetylators"

Page 37: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Anti-HIV

Fluoxetine; CCB, grapefruit

Prodrugs: Tamoxifen, codeine

See table 4-3

Page 38: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Question: Which of the following statements is correct?

1. The greater the number of receptors occupied by a drug, the greater the potency.

2. Drugs with high potency have a high EC50.3. Drugs with high potency have a drug DR curve that lies to the right

of a less potent drug4. The presence of a competitive antagonist shifts the agonist DR

curve to the right and decreases the potency5. The greater the drugs potency, the higher its drug receptor

dissociation constant, Kd. Ans. D The potency is the conc at which the drug elicits 50% max response. Very potent drugs have a low EC50. In 4, the binding of a competitive antagonist alters the equilbrium binding of the agonist. The greater a drugs potency the lower its Kd.

Page 39: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Question: What properties of certain drugs, such as aspirin, allow them to be taken without monitoring plasma drug levels, whereas heparin requires monitoring.

1. Whereas aspirin is taken orally, heparin is administered parenterally

2. Aspirin is available without prescription and can be taken safely

3. Whereas aspirin events are irreversible, which does not needmonitoring, the reversible effect of heparin must be monitored.

4. Whereas aspirin causes a graded DR relationship, heparin causes a Quantal DR relationship that must be monitored.

5. Whereas aspirin has a larger therapeutic index, heparin has a smallTI.

Ans. E. Heparin has a TI <2 I.e it can cause toxicity and bleeding at less than twice the therapeutic dose.

Page 40: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Your patient, Mr. S, is a 65-year old man that you are monitoring for elevated BP. His BP is 145/105 mm Hg this morning. You decide to to give a diuretic, thiazide and a beta-receptor blocker as an anti-hypertensive therapy. As you decide between atenolol and propranolol you remember that thiazide is 95% bound to albumin plasma protein.

Atenolol PropranololPlasma protein binding 5% 95%Urinary excretion 85% 1%

HOW DOES THE DIFFERENTIAL BINDING DETERMINE WHICH DRUG TO USE?A. Atenolol is less bound and so has less ability to reach the receptorB. Atenolol is less bound and so is less likely to interfere with plasma binding of thiazideC. Propranolol is highly bound, so it is less likely to displace thiazideD. Propranolol is highly bound, so it is more likely to compete with thiazideE. Propranolol is highly bound, so it will require a lower dose to achieve effect similar to

atenolol

Ans. B. Atenolol is less likely to displace thiazide. Propranolol is expected to displace thiazide. Drugs that are bound to plasma proteins may require a higher dose to achieve a therapeutic effect.

Page 41: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Ms. B is a 32-year old woman who complains of a sore throat. Physical exam reveals creamy white lesions on the tongue that is identified as oral thrush, a fungal infection. Her history includes sexual activity with multiple partners, inconsistent use of condoms. She is diagnosed wth an HIV-1 infection, confirmed by PCR. She is started on an anti-HIV regimen that includes the protease inhibitor sequinavir. Despite this treatment she presents several months later with a persistent cough that turns out to be TB.

Q. What factors should the physician consider when deciding a course of treatment with the anti-TB drug, Rifampin.

R. If oral thrush is present it will prevent GI absorption of oral contraceptivesS. The MDR1 transporter will block GI absorption of anti-TB agents in HIV patientsT. The metabolism of sequinavir will be enhanced by anti-TB drugsU. The metabolism will be enhanced by drinking grapefruit juiceV. Renal excretion of anti-TB drugs is prevented by sequinivir

Ans C. Rifampin induces P450 3A4 and so will enhance metabolism of sequiniavir. The MDR1 actively transports drugs back into the intestine. Grapefruit juice contains psoralen that inhibit P450 and so may reduce metabolism.

Page 42: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

CASE: Mr W is a 66 year old technology consultant. His only medical Problem is chronic atrial fibrillation, and his only medication is WARFARIN. He flies to Turkey where he eats shish kebabs. The next day he develops foul smelling diarrhea and his physician precribes a 7day course of trimethoprim-sulfamethoxazole.

He feels well for 2 days and goes on another dinner where much alcohol was consumed. Upon leaving the restaurant he falls and the next day hehas a swollen knee. Upon examination and lab studies show a elevatedInternational Normalized Ratio, which is a standardized measure of Prothrombin time- a surrogate marker of for warfarin levels.

The physician advises Mr W that his warfarin level is in the supra-Therapeutic (toxic) range and is likely the result of an adverse drug-Drug interaction between warfarin and the antibiotics (and the recentAlcohol!).

Page 43: Quantitative description of the effects of a drug on the body Quantitative, time-dependent changes of plasma and total drug concentration Pharmacokinetics.

Ans. A. Trimethoprim inhibited the hepatic metabolism of warfarin. In addition the ethanol also inhibited metabolism.

Q. What was the cause of Mr. W's supratherapeutic Warfarin level?

R. Trimethoprim inhibited the hepatic metabolism and clearanceS. Trimethoprim enhanced growth of GI bacteria that normallyDegrade warfarinC. Trimethoprim has an anticoagulant adverse effectD. Trimethoprim competed with warfarin for binding to its receptorE. Trimethoprim prevented the renal secretion of warfarin